Results 21 to 30 of about 1,763,654 (403)

Preventive measures against development of breast cancer

open access: yesЮжно-Российский онкологический журнал, 2021
According to Russian statistics, breast cancer ranks fi rst among malignant neoplasms among women (20.9%). The largest proportion of breast cancer cases is detected in women aged 35 to 55 years.
Yu. V. Vykhristyuk   +4 more
doaj   +1 more source

Unusual breast neoplasm: primary breast lymphoma [PDF]

open access: yesBMJ Case Reports, 2013
Primary breast lymphoma (PBL) is a rare clinical entity. The clinical and imaging findings in breast lymphoma can mimic those of breast carcinoma. As a result, the diagnosis of PBL relies on histological evaluation and confirmed by immunohistochemical staining. The treatment of choice of this rare disease is controversial.
Hassanali Vahedian   +3 more
openaire   +3 more sources

Prognostic Value of Bone Marrow Uptake Using 18F-FDG PET/CT Scans in Solid Neoplasms

open access: yesJournal of Imaging, 2022
Background: Fluorine-18-fluorodeoxyglucose positron emission tomography/computerized tomography (18F-FDG PET/CT) uptake is known to increase in infective and inflammatory conditions. Systemic inflammation plays a role in oncologic prognosis. Consequently,
Francisco Tustumi   +6 more
doaj   +1 more source

Exploring the interdependencies of research funders in the UK [PDF]

open access: yes, 2014
Investment in medical research is vital to the continuing improvement of the UK's health and wealth. It is through research that we expand our understanding of disease and develop new treatments for patients.
Crane, P   +13 more
core   +1 more source

Systematic assessment of HER2/neu in gynecologic neoplasms, an institutional experience. [PDF]

open access: yes, 2016
BackgroundHER2/neu overexpression and/or amplification has been widely studied in a number of solid tumors, primarily in the breast. In gynecologic neoplasms, determination of HER2/neu status has not been well studied as a predictive biomarker in anti ...
Apple, Sophia K   +5 more
core   +2 more sources

Neuroendocrine neoplasms of the breast: A review focused on the updated World Health Organization (WHO) 5th Edition morphologic classification

open access: yesThe Breast Journal, 2020
Neuroendocrine breast neoplasms are uncommon invasive carcinomas that have historically been poorly defined due to various definitions of what constitutes a neuroendocrine carcinoma.
F. Pareja, Timothy D’alfonso
semanticscholar   +1 more source

A novel combination of triple metachronous malignancies of the kidney, oropharynx and prostate. A case report [PDF]

open access: yes, 2015
Synchronous or metachronous malignancies are a rare event, with an incidence rate that increases with age. The present study reports the case of a 70-year-old Caucasian male who was referred to the outpatient office of the Urology Unit, Sapienza ...
Carbone, Antonio   +6 more
core   +1 more source

Primary Neuroendocrine Neoplasms of the Breast: Case Series and Literature Review

open access: yesCancers, 2020
Primary neuroendocrine carcinoma of the breast (NECB) as defined by the World Health Organization (WHO) in 2012 is a rare, but possibly under-diagnosed entity.
Burcin Özdirik   +8 more
semanticscholar   +1 more source

Circulating secretory component in breast neoplasms. [PDF]

open access: yesJournal of Clinical Pathology, 1987
The serum concentrations of IgAp and IgMr associated secretory component (SIgA and SIgM) of 98 patients with neoplasms of the breast were measured. Of the 56 patients with carcinomas, 11 had increased concentrations of circulating SIgM, which was almost twice as sensitive as SIgA as a marker for carcinoma.
D. Kvale   +5 more
semanticscholar   +4 more sources

PET/CT incidental detection of second tumor in patients investigated for pancreatic neoplasms [PDF]

open access: yes, 2018
Positron Emission Tomography/computed tomography (PET/CT) is an imaging technique which has a role in the detection and staging malignancies (both in first diagnosis and follow-up).
Bissoli, Sergio   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy